Lower HIV-2 plasma viral loads may explain differences between the natural histories of HIV-1 and HIV-2 infections

Journal of Acquired Immune Deficiency Syndromes

Volumn 24, Issue 3, 2000, Pages 257-263

  Shanmugam, Vedapuri ^a   Switzer, William M ^a   Nkengasong, John N ^b   García Lerma, Gerardo ^a   Green, Timothy A ^a   Ekpini, Ehounou ^b   Sassan Morokro, Madeleine ^b   Antunes, Francisco ^c   Manshino, Kamal ^c   Soriano, Vincent ^d   Wiktor, Stefan Z ^b   Heneine, Walid ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c Hospital de Belem and Hospital Egas Mouiz   (Portugal)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Amp RT; Epidemiology; HIV 1; HIV 2; Natural history; Viral load

Indexed keywords

RNA DIRECTED DNA POLYMERASE; VIRUS RNA;

ARTICLE; COTE D'IVOIRE; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN TISSUE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PORTUGAL; PRIORITY JOURNAL; VIRUS LOAD; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS TRANSMISSION;

EID: 0034232749     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-200007010-00011     Document Type: Article

References (40)

1. Serological evidence for virus related to simian T-lymphotropic mtro-virus III in residents of West Africa
2. New human T-lymphotropic retrovirus related to simian T-lymphotropic virus type III (STLV-IIIAGM)
3. Isolation of a new human retrovirus from West African patients with AIDS
4. Towards a better understanding of the epidemiology of HIV-2
5. Human immunodeficiency virus type 2 (HIV-2)
6. Epidemiology and Transmission of HIV-2. Why there is no HIV-2 pandemic
7. Cellular and plasma viral load in patients infected with HIV-2
8. + lymphopenia in HIV type 2-infected individuals
9. A community based study of human immunodeficiency virus type 2 provirus load in a rural village in West Africa
10. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion
11. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
12. Low peripheral blood HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection
13. Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2
14. Detection of reverse transcriptase by a highly sensitive assay in sera from persons infected with Human Immunodeficiency Virus Type 1
15. Highly sensitive qualitative and quantitative detection of reverse transcriptase activity: Optimization, validation, and comparative analysis with other detection systems
16. Measurement of Human immunodeficiency virus type 1 plasma virus load based on reverse transcriptase (RT) activity: Evidence of variabilities in levels of virion associated RT
17. Rapid screening of phenotypic resistance to nevirapine by direct analysis of HIV type 1 reverse transcriptase activity in plasma
18. Tuberculosis and HIV infection in sub-Saharan Africa
19. WHO case definitions for AIDS surveillance in adults and adolescents
20. Prospective comparison of mother-to-child transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast
21. The Cote d'Ivoire national HIV counseling and testing program for tuberculosis patients: Implementation and analysis of epidemiologic data
22. Rapid and specific diagnosis of HIV-1 and HIV-2 infection. An evaluation of testing strategies
23. Status of long-term asymptomatic HIV-1 infection correlates with viral load but not with virus replication properties and cell tropism
24. Sexual transmission of HIV
25. Association of CD4 cell depletion and elevated blood and seminal plasma human immunodeficiency virus type 1 (HIV-1) RNA concentrations with genital ulcer disease in HIV-1-infected men in Malawi
26. The Ariel Project: A prospective cohort study of maternal-child transmission of human immunodeficiency virus type 1 in the era of maternal antiretroviral therapy
27. A one-tube quantitative HIV-1 RNA NASBA nucleic acid amplification assay using electrochemiluminescent (ECL) labeled probes
28. Direct and quantitative detection of HIV-1 RNA in human plasma with a branched DNA signal amplification assay
29. Autologous neutralizing antibodies and viral load in HIV-2-infected individuals
30. Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection
31. Comparison of plasma cytokine levels in African patients with HIV-1 and HIV-2 infection
32. HIV-2-specific cytotoxic T-lymphocyte activity is inversely related to proviral load
33. Importance of the nef gene for maintenance of high virus loads and for development of AIDS
34. Evidence of nef truncation in human immunodeficiency virus type 2 infection
35. Human immunodeficiency virus type 1 subtypes differ in disease progression
36. Predominance of human immunodeficiency virus type 2 subtype B in Abidjan, Ivory Coast
37. High levels of HIV-1 plasma during all stages of infection determined by competitive PCR
38. Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess clinical benefit of antiretroviral therapy
39. Antiretroviral therapy for HIV infection in 1998
40. Report of the NIH panel to define principles of therapy of HIV infection and guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents